ES2063154T3 - Vacuna asociada por afinidad. - Google Patents

Vacuna asociada por afinidad.

Info

Publication number
ES2063154T3
ES2063154T3 ES89402344T ES89402344T ES2063154T3 ES 2063154 T3 ES2063154 T3 ES 2063154T3 ES 89402344 T ES89402344 T ES 89402344T ES 89402344 T ES89402344 T ES 89402344T ES 2063154 T3 ES2063154 T3 ES 2063154T3
Authority
ES
Spain
Prior art keywords
vaccine
affinity associated
associated vaccine
disclosed
infective agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89402344T
Other languages
English (en)
Inventor
Mircea C Popescu
Marie S Recine
Carl L Alving
Leonard F Estis
Lynn D Keyes
Andrew S Janoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ES2063154T3 publication Critical patent/ES2063154T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01RELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R13/00Details of coupling devices of the kinds covered by groups H01R12/70 or H01R24/00 - H01R33/00
    • H01R13/46Bases; Cases
    • H01R13/52Dustproof, splashproof, drip-proof, waterproof, or flameproof cases
    • H01R13/5202Sealing means between parts of housing or between housing part and a wall, e.g. sealing rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE UNA VACUNA CONTRA UN AGENTE INFECCIOSO, VACUNA QUE CONTIENE UN LIPOSOMA QUE TIENE UN EXTERIOR Y UN INTERIOR Y QUE TIENE DISPUESTO EXTERNAMENTE MATERIAL ANTIGENO RELACIONADO CON AFINIDAD DE POR LO MENOS UN, PREFERIBLEMENTE NO DIVISOR, ANTIGENO REPRESENTATIVO DE DICHO AGENTE INFECCIOSO. TAMBIEN SE DESCRIBE UN METODO PARA PREPARAR Y USAR ESTA VACUNA.
ES89402344T 1988-08-25 1989-08-25 Vacuna asociada por afinidad. Expired - Lifetime ES2063154T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23670288A 1988-08-25 1988-08-25
US23670188A 1988-08-25 1988-08-25
US39775889A 1989-08-23 1989-08-23

Publications (1)

Publication Number Publication Date
ES2063154T3 true ES2063154T3 (es) 1995-01-01

Family

ID=27398904

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89402344T Expired - Lifetime ES2063154T3 (es) 1988-08-25 1989-08-25 Vacuna asociada por afinidad.

Country Status (6)

Country Link
EP (1) EP0356340B1 (es)
AT (1) ATE113472T1 (es)
DE (1) DE68919173T2 (es)
ES (1) ES2063154T3 (es)
GR (1) GR3014900T3 (es)
NZ (1) NZ230424A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1093255A (zh) * 1986-06-17 1994-10-12 恩特雷麦德有限公司 抗甾醇疫苗
JPH0334920A (ja) * 1989-04-21 1991-02-14 Otsuka Pharmaceut Co Ltd リポソームに結合及至組合わされた生物活性化合物及びそれを含有する医薬
NL9000207A (es) * 1990-01-29 1991-08-16 Duphar Int Res
IL97985A0 (en) * 1990-05-07 1992-06-21 North American Vaccine Inc Improved vaccine compositions
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
JP3183665B2 (ja) * 1990-12-10 2001-07-09 エントルメド インコーポレーテッド コレステロール過剰血症およびアテローム性動脈硬化を防止するためのコレステロールに体するワクチン
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
WO1994016061A1 (en) * 1993-01-15 1994-07-21 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
AU677826B2 (en) * 1993-02-26 1997-05-08 Fountain Pharmaceuticals, Inc. Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients
WO1995016437A1 (en) * 1993-12-17 1995-06-22 Micro-Pak, Inc. Method of transmitting a biologically active material to a cell
BR9506885A (pt) * 1994-02-24 1997-08-19 Micro Pak Inc Vacinas contendo vesículas de lipidio paucilamelares como adjuvantes imunológicos
GB0318096D0 (en) 2003-08-01 2003-09-03 Queen Mary & Westfield College Vaccine
EP1550458A1 (en) * 2003-12-23 2005-07-06 Vectron Therapeutics AG Synergistic liposomal adjuvants
GB0426481D0 (en) 2004-12-02 2005-01-05 Vaccine Technology Ltd Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) * 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes

Also Published As

Publication number Publication date
EP0356340B1 (en) 1994-11-02
DE68919173T2 (de) 1995-03-09
EP0356340A1 (en) 1990-02-28
GR3014900T3 (en) 1995-05-31
ATE113472T1 (de) 1994-11-15
DE68919173D1 (de) 1994-12-08
NZ230424A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
ES2063154T3 (es) Vacuna asociada por afinidad.
DE69004426D1 (de) Gassackzusammenbau.
DE3789761D1 (de) Reibungsmaterialien und Herstellung derselben.
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
DE69016049D1 (de) Fahrzeug-Aufbaustrukturen und Herstellungsweise.
NO895176D0 (no) Fremgangsmaate ved fremstilling av mono-n-alkylerte polyazamakrocykler.
DE68924305D1 (de) Selbsttätiges programmierungsverfahren.
DE68909152D1 (de) Druckluftventil und Trennvorrichtung.
JPS57172952A (en) Hydrophilic formation material comprising homopolyester and/or copolyester, manufacture and fiber made therefrom
TR27110A (tr) Seramik ve siramik bilesik yapilar üretme yöntemi.
DK190889A (da) Antigen
DE68917740D1 (de) Klimaanlage.
DE59003529D1 (de) Ringförmiger Federkörper aus Faserverbundwerkstoff.
NO892269D0 (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
TR22459A (tr) 1,3,2,dioksaborinan'lar bunlarin ueretilmesine mahsus usulleri ve bunlari ihtiva eden biosid maddeler
DE68922889D1 (de) Bildaufzeichnungsverfahren und Material.
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
NO903566D0 (no) Saape med forbedret sprekkfasthet samt fremgangsmaate for fremstilling derav.
PT89996A (pt) Processo para a preparacao de 3-(2,3,4,5,6-pentafluorofenoxi)-8-azabiciclo{3.2.1}octanos
NZ224862A (en) Taenia ovis antigens and vaccines
FR2665680B2 (fr) Hydroptere a coussin d'air ameliore.
IT8840172A0 (it) Procedimento e mezzi per l'impressione in rilievo di tessuti, o pelli e simili
DE58903418D1 (de) Luftkissenfahrzeug.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 356340

Country of ref document: ES